StreetInsider.com News Articles

4DMT Announces New Employment Inducement Grants

Fri, 11 Sep 2026 16:05:00 -0400

EMERYVILLE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on September 8, 2026, the compensation committee of the Company’s board of directors granted seven new non-executive employees 96,000 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, as amended, under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into

4DMT Announces New Employment Inducement Grants

Fri, 11 Sep 2026 16:05:00 -0400

Form 4 4D Molecular Therapeutic For: Aug 19 Filed by: Kirn David

Fri, 21 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260821/26961418.html

Form 4 4D Molecular Therapeutic For: Aug 19 Filed by: Kirn David

Fri, 21 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260821/26961418.html

Form 144 4D Molecular Therapeutic Filed by: Kirn David

Wed, 19 Aug 2026 18:29:00 -0400

si-local-file:///var/storage/secattach/20260819/26951434.html

Form 144 4D Molecular Therapeutic Filed by: Kirn David

Wed, 19 Aug 2026 18:29:00 -0400

si-local-file:///var/storage/secattach/20260819/26951434.html

Form 4 4D Molecular Therapeutic For: Aug 13 Filed by: Bizily Scott

Mon, 17 Aug 2026 17:34:00 -0400

si-local-file:///var/storage/secattach/20260817/26939041.html

Form 4 4D Molecular Therapeutic For: Aug 13 Filed by: Bizily Scott

Mon, 17 Aug 2026 17:34:00 -0400

si-local-file:///var/storage/secattach/20260817/26939041.html

Form 144 4D Molecular Therapeutic Filed by: Bizily Scott

Mon, 17 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260817/26938580.html

Form 144 4D Molecular Therapeutic Filed by: Bizily Scott

Mon, 17 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260817/26938580.html

H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)

Fri, 14 Aug 2026 06:50:36 -0400

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating and $36.00 price target on 4D Molecular Therapeutics (NASDAQ: FDMT).

The analyst commented: "The company continues to execute its pivotal 4D-150 gene therapy Phase 3 4FRONT-1 North American trial (100% treatment naïve), and the parallel Phase 3 4FRONT-2 global trial (60% treatment naïve, 40% previously treated and diagnosed within 6-months). Notably, the 4FRONT-2 trial has now completed enrollment with topline from the trials anticipated in 2Q27 and 2H27, respectively. We note this progress builds on recent positive 2-year data from the Phase 2b PRISM trial in wet AMD, notably based on single

4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c

Thu, 13 Aug 2026 16:40:24 -0400

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported Q2 EPS of ($1.04), $0.03 worse than the analyst estimate of ($1.01). Revenue for the quarter came in at $3.78 million versus the consensus estimate of $2.66 million.

For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.

Form 144 4D Molecular Therapeutic Filed by: Bizily Scott

Thu, 13 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260813/26921970.html

Form 144 4D Molecular Therapeutic Filed by: Bizily Scott

Thu, 13 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260813/26921970.html

Form 10-Q 4D Molecular Therapeutic For: Jun 30

Thu, 13 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260813/26921092.html

Form 10-Q 4D Molecular Therapeutic For: Jun 30

Thu, 13 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260813/26921092.html

Form 8-K 4D Molecular Therapeutic For: Aug 13

Thu, 13 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260813/26920933.html

Form 8-K 4D Molecular Therapeutic For: Aug 13

Thu, 13 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260813/26920933.html

Form 4 4D Molecular Therapeutic For: Aug 04 Filed by: Kirn David

Wed, 05 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260805/26874297.html

Form 4 4D Molecular Therapeutic For: Aug 04 Filed by: Kirn David

Wed, 05 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260805/26874297.html

Form 144 4D Molecular Therapeutic Filed by: Kirn David

Tue, 04 Aug 2026 18:09:00 -0400

si-local-file:///var/storage/secattach/20260804/26868315.html

Form 144 4D Molecular Therapeutic Filed by: Kirn David

Tue, 04 Aug 2026 18:09:00 -0400

si-local-file:///var/storage/secattach/20260804/26868315.html

Form 4 4D Molecular Therapeutic For: Aug 03 Filed by: Kirn David

Tue, 04 Aug 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260804/26867389.html

Form 4 4D Molecular Therapeutic For: Aug 03 Filed by: Kirn David

Tue, 04 Aug 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260804/26867389.html

Form 144 4D Molecular Therapeutic Filed by: Kirn David

Mon, 03 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260803/26859513.html